New protein “switch” could be key to controlling blood-poisoning and preventing death

Date Posted: 
2019-02-25

February 25, 2019 - Scientists at the University of British Columbia have discovered a new protein “switch” that could stop the progression of blood-poisoning, or sepsis, and increase the chances of surviving the life-threatening disease.

Sepsis, an inflammatory disease that arises when the body’s response to an infection injures its own tissues and organs, causes an estimated 14 million deaths every year. In a study published recently in Immunity, researchers examined the role of a protein called ABCF1 in regulating the progression of sepsis.

“Sepsis triggers an uncontrolled chain-reaction of inflammation in the body, leading to tissue damage, organ failure, and death,” said Hitesh Arora, co-lead author of the study who conducted this research as a PhD student at the Michael Smith Laboratories at UBC. “We have discovered that the enzyme ABCF1 acts as a ‘switch’ at the molecular level that can stop this inflammatory chain-reaction and dampen the potential damage.”

Sepsis is hard to diagnose. With no specific course of treatment, management of the disease for the 30 million people who develop it each year relies on infection control and organ-function support.

Scientists do know that sepsis occurs in two phases. The first phase is known as systemic inflammatory response syndrome (SIRS) and results in a “cytokine storm,” a dramatic increase in immune cells such as macrophages, a type of white blood cell. This results in inflammation and a decrease in anti-inflammatory cells, leading to chemical imbalances in blood and damage to tissues and organs. Recovery starts to takes place when the body enters a second phase called the endotoxin tolerance (ET) phase, where the opposite occurs.

Building on previous knowledge of ABCF1 as part of a family of proteins that plays a key role in the immune system, the researchers examined its role in white blood cells during inflammation in a mouse model of sepsis.

They discovered that ABCF1 had the ability to act as a “switch” in sepsis to transition from the initial SIRS phase into the ET phase and regulate the “cytokine storm.” Furthermore, without the ABCF1 switch, immune responses are stalled in the SIRS phase, causing severe tissue damage and death.

The discovery opens up the potential for new treatments for chronic and acute inflammatory diseases, as well as auto-immune diseases.

“Our study may lead to therapies that overcome inflammatory and auto- immune disease such as rheumatoid arthritis, inflammatory bowel disease, Crohn’s disease, and ulcerative colitis,” says senior author Wilfred Jefferies, a professor at the Michael Smith Laboratories and departments of medical genetics and microbiology and immunology at UBC.

The research was conducted in collaboration with the Vancouver Prostate Centre, a Vancouver Coastal Health Research Institute (VCHRI) research centre, and was funded by the Canadian Institutes of Health Research (CIHR).

Visit the original article on UBC News here.

Read the Science in the City article here.

Contact information:
Tracy Pham
Marketing and Communications Coordinator,<
Michael Smith Laboratories
Email: tracy [dot] phamatmsl [dot] ubc [dot] ca
Phone: 604 822 1164

 

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Plaid for Dad

Plaid for Dad Fundraiser, June 14, 2019

Plaid for Dad is a workplace fundraiser for Prostate Cancer Canada, with online registration & fundraising leading up to Friday June 14th's "wear plaid to work" day. Visit the event website to register a team, join/fundraise for a team or buy plaid to wear on the day.      

Fathers Day Walk Run 2019

Raymond James Father's Day Walk Run Fundraiser, June 16, 2019

The 21st Annual Raymond James Walk Run fundraiser for Prostate Cancer Foundation BC takes place on Sunday June 16, 2019 in various locations across BC. Registration fees ($40) include a shirt and BBQ lunch, and are waived for those who raise over $150. Click here to sponsor our Centre's team (opens in new window).

 

Employment

Work at the Vancouver Prostate Centre

Friday, May 3, 2019

Dr. Mads Daugaard receives the St. Baldrick’s Foundation Robert J. Arceci Innovation Award

Dr. Daugaard
Thursday, April 18, 2019

Dr. Subramaniam joins UBC as Gobind Khorana Canada Excellence Research Chair in Precision Cancer Drug Design

Dr. Subramaniam
Monday, April 1, 2019

VPC's translational research profiled in UBC Faculty of Medicine News

Dr. Gleave at the VPC